Abstract
The purpose of this study was to evaluate the sensitivities of quantitative susceptibility mapping (QSM) and R2* mapping in clinical diagnoses of Parkinson’s disease (PD). QSM images and R2* maps from 29 patients with PD and 25 healthy controls were obtained on a clinical 3T magnetic resonance imaging (MRI) system using a three-dimensional multi-echo gradient-echo sequence. Two-tailed t tests and receiver operating characteristic curves analyses were applied to the mean values of QSM and R2* of the two groups. In the PD group, a two-tailed Pearson correlation analysis was used to investigate the correlations between MRI measures (susceptibility and R2* values) and the Unified Parkinson’s Disease Rating Scale-III (UPDRS-III) score. In the substantia nigra (SN), a significant difference between patients with PD and healthy controls was found on QSM (154.80 ± 43.36 vs. 127.50 ± 21.05 ppb, P = 0.006) but not on R2* mapping. The receiver operating characteristic curves showed that QSM was more sensitive than R2* mapping to distinguish PD patients from healthy controls, with areas under the curve equal to 0.68 and 0.51, respectively. The UPDRS-III motor scores did not correlate with mean susceptibility or R2* values in the PD group. In conclusion, QSM is a more accurate and sensitive method than R2* mapping to detect the pathologic changes in the SN of patients with PD.
Similar content being viewed by others
References
P. Damier, E.C. Hirsch, Y. Agid, A.M. Graybiel, Brain 122(Pt 8), 1437–1448 (1999)
K. Seppi, W. Poewe, Neuroimaging Clin. N. Am. 20, 29–55 (2010)
S. Baudrexel, L. Nurnberger, U. Rub, C. Seifried, J.C. Klein, T. Deller, H. Steinmetz, R. Deichmann, R. Hilker, Neuroimage 51, 512–520 (2010)
R.A. Menke, J. Scholz, K.L. Miller, S. Deoni, S. Jbabdi, P.M. Matthews, M. Zarei, Neuroimage 47, 435–441 (2009)
J. Vymazal, A. Righini, R.A. Brooks, M. Canesi, C. Mariani, M. Leonardi, G. Pezzoli, Radiology 211, 489–495 (1999)
D. Aquino, V. Contarino, A. Albanese, L. Minati, L. Farina, M. Grisoli, L. Romita, A.E. Elia, M.G. Bruzzone, L. Chiapparini, Neuroscience 35, 753–758 (2014)
M. Gerlach, K.L. Double, M.B. Youdim, P. Riederer, J. Neural Transm. Suppl. 70, 133–142 (2006)
Z. Lv, H. Jiang, H. Xu, N. Song, J. Xie, J. Neural. Transm. 118, 361–369 (2011)
L. Zecca, A. Stroppolo, A. Gatti, D. Tampellini, M. Toscani, M. Gallorini, G. Giaveri, P. Arosio, P. Santambrogio, R.G. Fariello, E. Karatekin, M.H. Kleinman, N. Turro, O. Hornykiewicz, F.A. Zucca, Proc. Natl. Acad. Sci. USA 101, 9843–9848 (2004)
P. Peran, A. Cherubini, F. Assogna, F. Piras, C. Quattrocchi, A. Peppe, P. Celsis, O. Rascol, J.F. Demonet, A. Stefani, M. Pierantozzi, F.E. Pontieri, C. Caltagirone, G. Spalletta, U. Sabatini, Brain 133, 3423–3433 (2010)
I. Nestrasil, S. Michaeli, T. Liimatainen, C.E. Rydeen, C.M. Kotz, J.P. Nixon, T. Hanson, P.J. Tuite, J. Neurol. 257, 964–968 (2010)
E.M. Haacke, Y. Miao, M. Liu, C.A. Habib, Y. Katkuri, T. Liu, Z. Yang, Z. Lang, J. Hu, J. Wu, J. Magn. Reson. Imaging 32, 561–576 (2010)
J.M. Graham, M.N. Paley, R.A. Grunewald, N. Hoggard, P.D. Griffiths, Brain 123(Pt 12), 2423–2431 (2000)
B.H. Braffman, R.I. Grossman, H.I. Goldberg, M.B. Stern, H.I. Hurtig, D.B. Hackney, L.T. Bilaniuk, R.A. Zimmerman, A.J.R. Am, J. Roentgenol. 152, 159–165 (1989)
F. Mondino, P. Filippi, U. Magliola, S. Duca, Neurol. Sci. 23(Suppl 2), S87–S88 (2002)
A.J. Walsh, A.H. Wilman, Neuroimage 57, 452–461 (2011)
W. Li, B. Wu, C. Liu, Neuroimage 55, 1645–1656 (2011)
L. de Rochefort, T. Liu, B. Kressler, J. Liu, P. Spincemaille, V. Lebon, J. Wu, Y. Wang, Magn. Reson. Med. 63, 194–206 (2010)
Y. Wang, T. Liu, Magn. Reson. Med. 73, 82–101 (2015)
T. Liu, W. Xu, P. Spincemaille, A.S. Avestimehr, Y. Wang, I.E.E.E. Trans. Med. Imaging 31, 816–824 (2012)
E.M. Haacke, S. Liu, S. Buch, W. Zheng, D. Wu, Y. Ye, Magn. Reson. Imaging 33, 1–25 (2015)
C. Liu, W. Li, K.A. Tong, K.W. Yeom, S. Kuzminski, J. Magn. Reson. Imaging 42, 23–41 (2015)
C. Langkammer, F. Schweser, N. Krebs, A. Deistung, W. Goessler, E. Scheurer, K. Sommer, G. Reishofer, K. Yen, F. Fazekas, S. Ropele, J.R. Reichenbach, Neuroimage 62, 1593–1599 (2012)
J. Li, S. Chang, T. Liu, Q. Wang, D. Cui, X. Chen, M. Jin, B. Wang, M. Pei, C. Wisnieff, P. Spincemaille, M. Zhang, Y. Wang, Magn. Reson. Med. 68, 1563–1569 (2012)
Y. Murakami, S. Kakeda, K. Watanabe, I. Ueda, A. Ogasawara, J. Moriya, S. Ide, K. Futatsuya, T. Sato, K. Okada, T. Uozumi, S. Tsuji, T. Liu, Y. Wang, Y. Korogi, Am. J. Neuroradiol. 36, 1102–1108 (2015)
A.K. Lotfipour, S. Wharton, S.T. Schwarz, V. Gontu, A. Schafer, A.M. Peters, R.W. Bowtell, D.P. Auer, P.A. Gowland, N.P. Bajaj, J. Magn. Reson. Imaging 35, 48–55 (2012)
J.H. Barbosa, A.C. Santos, V. Tumas, M. Liu, W. Zheng, E.M. Haacke, C.E. Salmon, Magn. Reson. Imaging 33, 559–565 (2015)
A. Ojelade, T. Jia, A.R. Rodan, T. Chenyang, J.L. Kadrmas, A. Cattrell, B. Ruggeri, P. Charoen, H. Lemaitre, T. Banaschewski, C. Buchel, A.L. Bokde, F. Carvalho, P.J. Conrod, H. Flor, V. Frouin, J. Gallinat, H. Garavan, P.A. Gowland, A. Heinz, B. Ittermann, M. Lathrop, S. Lubbe, J.L. Martinot, T. Paus, M.N. Smolka, R. Spanagel, P.F. O’Reilly, J. Laitinen, J.M. Veijola, J. Feng, S. Desrivieres, M.R. Jarvelin, I. Consortium, G. Schumann, A. Rothenfluh, Proc. Natl. Acad. Sci. USA 112, E4085–E4093 (2015)
G. Du, T. Liu, M.M. Lewis, L. Kong, Y. Wang, J. Connor, R.B. Mailman, X. Huang, Mov. Disord. 31(3), 317–324 (2016)
J. Liu, T. Liu, L. de Rochefort, J. Ledoux, I. Khalidov, W. Chen, A.J. Tsiouris, C. Wisnieff, P. Spincemaille, M.R. Prince, Y. Wang, Neuroimage 59, 2560–2568 (2012)
T. Liu, C. Wisnieff, M. Lou, W. Chen, P. Spincemaille, Y. Wang, Magn. Reson. Med. 69, 467–476 (2013)
R. Cusack, N. Papadakis, Neuroimage 16, 754–764 (2002)
T. Liu, I. Khalidov, L. de Rochefort, P. Spincemaille, J. Liu, A.J. Tsiouris, Y. Wang, NMR Biomed. 24, 1129–1136 (2011)
W. Chen, S.A. Gauthier, A. Gupta, J. Comunale, T. Liu, S. Wang, M. Pei, D. Pitt, Y. Wang, Radiology 271, 183–192 (2014)
W. Chen, W. Zhu, I. Kovanlikaya, A. Kovanlikaya, T. Liu, S. Wang, C. Salustri, Y. Wang, Radiology 270, 496–505 (2014)
C. Wisnieff, S. Ramanan, J. Olesik, S. Gauthier, Y. Wang, D. Pitt, Magn. Reson. Med. 74, 564–570 (2015)
B. Xu, T. Liu, P. Spincemaille, M. Prince, Y. Wang, Magn. Reson. Med. 72, 438–445 (2014)
A. Groger, D. Berg, J. Neural. Transm. 119, 1523–1528 (2012)
A. Schafer, B.U. Forstmann, J. Neumann, S. Wharton, A. Mietke, R. Bowtell, R. Turner, Hum. Brain Mapp. 33, 2831–2842 (2012)
Acknowledgements
This study was supported in part by grants from The National Natural Science Foundation of China (81271533) and Shanghai Municipal Commission of Health and Family Planning (201540392). We thank Kelly Gillen for English editing.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare.
Rights and permissions
About this article
Cite this article
Zhao, X., An, H., Liu, T. et al. Quantitative Susceptibility Mapping of the Substantia Nigra in Parkinson’s Disease. Appl Magn Reson 48, 533–544 (2017). https://doi.org/10.1007/s00723-017-0877-x
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00723-017-0877-x